Previous 10 | Next 10 |
Strategic collaboration will bolster 22nd Century’s position as a global leader in hemp/cannabis genetics. 22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and h...
22nd Century has had more than 20 conversations with the FDA on matters relating to the Company’s PMT and MRTP applications 22nd Century will substantially increase Company’s investment in hemp/cannabis 22nd Century Group, Inc. (NYSE American: XXII ), a plant biote...
22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is focused on tobacco harm reduction and hemp/cannabis research, announced today the results of a recently completed, company-sponsored study involving 22nd Century’s Very Low Nicotine Content (VLNC) c...
22nd Century Group, Inc. (XXII) Q4 2018 Earnings Conference Call March 7, 2019 4:00 PM ET Company Participants Thomas James – Vice President, General Counsel and Corporate Secretary John Brodfuehrer – Chief Financial Officer Henry Sicignano – Chief Executive ...
22nd Century (NYSEMKT: XXII ): Q4 GAAP EPS of -$0.07. More news on: 22nd Century Group, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
The FDA has accepted for review the Company’s MRTPA for VLN TM cigarettes 22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is focused on tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, announc...
Bio-Path Holdings (NASDAQ: BPTH ) +55% on positive prexigebersen data. More news on: Bio-Path Holdings, Inc., Abercrombie & Fitch, China Automotive Systems, Inc., Stocks on the move, Read more ...
SAN DIEGO, March 05, 2019 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in NYSE: XXII shares over alleged securities laws violations by 22nd Century Group, Inc. Investors, who purchased shares of 22nd Century Group, In...
NEW YORK, NY / ACCESSWIRE / March 3, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Brons...
NEW YORK, Feb. 16, 2019 (GLOBE NEWSWIRE) -- Stull, Stull & Brody announces that a derivative lawsuit has been filed on behalf of holders of 22nd Century Group’s (NYSE American: XXII ) stock, and that it is investigating potential claims on behalf of 22nd Century Group. The Com...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NASDAQ Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...